# Carie Boyd Pharmaceuticals LLC, Irving, TX – FDA Inspections Source: https://www.keypedia.com/companies/carie-boyd-pharmaceuticals-llc/24f4bfa5-78f1-4183-9c57-f52415673fb6 > Inspection records and compliance data for Carie Boyd Pharmaceuticals LLC in Irving, Texas. 7 FDA inspections on record (4 OAI), 3 Form 483s, last inspected September 08, 2026. --- ## Details - Name: Carie Boyd Pharmaceuticals LLC - FEI Number: 3010589333 - Facility Type: 503B Facility - Address Line 1: 8400 Esters Blvd Ste 190 - City: Irving - State: Texas - Zip Code: 75063 - Country Name: United States - Address: 8400 Esters Blvd Ste 190, Irving, Texas 75063, United States - Country: United States ## Related Documents - [483 - Carie Boyd Pharmaceuticals LLC - 2026-09-08](https://www.keypedia.com/records/483/carie-boyd-pharmaceuticals-llc/18721e34-19c0-433a-a574-f7a130c56539) — source: FDA, date: September 8, 2026 - [FDA Inspection 1334806 - Carie Boyd Pharmaceuticals LLC - 2026-09-08](https://www.keypedia.com/records/fda_inspections/carie-boyd-pharmaceuticals-llc/cafbcd7d-0543-4bd0-bec6-2991e862ecc2) — source: FDA, date: September 8, 2026 - [483 - Carie Boyd Pharmaceuticals LLC - 2025-07-18](https://www.keypedia.com/records/483/carie-boyd-pharmaceuticals-llc/2deda8cd-4eb4-4829-8ad3-697faf7ab78b) — source: FDA, date: July 18, 2025 - [FDA Inspection 1275006 - Carie Boyd Pharmaceuticals LLC - 2025-07-18](https://www.keypedia.com/records/fda_inspections/carie-boyd-pharmaceuticals-llc/095b4bfe-cd8e-4e95-8485-7617c840de0f) — source: FDA, date: July 18, 2025 - [483 - Carie Boyd Pharmaceuticals LLC - 2024-06-21](https://www.keypedia.com/records/483/carie-boyd-pharmaceuticals-llc/5b2ecea5-4ff6-4441-839a-70029258d990) — source: FDA, date: June 21, 2024 - [FDA Inspection 1241822 - Carie Boyd Pharmaceuticals LLC - 2024-06-21](https://www.keypedia.com/records/fda_inspections/carie-boyd-pharmaceuticals-llc/1a6c0434-3386-43dc-a5c3-0c0f31dd929f) — classification: Official Action Indicated (OAI), source: FDA, date: June 21, 2024 - [483 - Carie Boyd Pharmaceuticals LLC - 2022-06-27](https://www.keypedia.com/records/483/carie-boyd-pharmaceuticals-llc/df64ad66-c145-447e-a16f-81cf30eaac03) — source: FDA, date: June 27, 2022 - [FDA Inspection 1172848 - Carie Boyd Pharmaceuticals LLC - 2022-06-27](https://www.keypedia.com/records/fda_inspections/carie-boyd-pharmaceuticals-llc/f72e078f-a8ee-4006-883d-78234f6f2c9f) — classification: Official Action Indicated (OAI), source: FDA, date: June 27, 2022 - [483 - Carie Boyd Pharmaceuticals LLC - 2019-11-12](https://www.keypedia.com/records/483/carie-boyd-pharmaceuticals-llc/d656a35b-9ab9-4e94-ac62-10ec9e31a515) — source: FDA, date: November 12, 2019 - [FDA Inspection 1109663 - Carie Boyd Pharmaceuticals LLC - 2019-11-12](https://www.keypedia.com/records/fda_inspections/carie-boyd-pharmaceuticals-llc/5952d58b-2fad-4681-8f34-e1c80067edfc) — classification: Official Action Indicated (OAI), source: FDA, date: November 12, 2019 - [UNTITLED_LETTER - Carie Boyd Pharmaceuticals LLC - 2019-10-25](https://www.keypedia.com/records/untitled_letter/carie-boyd-pharmaceuticals-llc/be247c58-24d0-4e53-af75-8b9e8e1e8669) — source: FDA, date: October 25, 2019 - [483 - Carie Boyd Pharmaceuticals LLC - 2017-05-12](https://www.keypedia.com/records/483/carie-boyd-pharmaceuticals-llc/8f38d096-dbce-4060-9c67-08394588ab94) — source: FDA, date: May 12, 2017 - [FDA Inspection 1012941 - Carie Boyd Pharmaceuticals LLC - 2017-05-12](https://www.keypedia.com/records/fda_inspections/carie-boyd-pharmaceuticals-llc/ef9f4bb3-2f7f-4b21-84d0-4fef64161823) — classification: Voluntary Action Indicated (VAI), source: FDA, date: May 12, 2017 - [483 - Carie Boyd Pharmaceuticals LLC - 2014-12-12](https://www.keypedia.com/records/483/carie-boyd-pharmaceuticals-llc/d1626bba-d241-476e-981d-4026d5a5e0f6) — source: FDA, date: December 12, 2014 - [FDA Inspection 908025 - Carie Boyd Pharmaceuticals LLC - 2014-12-12](https://www.keypedia.com/records/fda_inspections/carie-boyd-pharmaceuticals-llc/8003c0ac-4c79-44bc-84e2-3b9c343668ab) — classification: Official Action Indicated (OAI), source: FDA, date: December 12, 2014 ## Related Companies - [QuVa Pharma, Inc.](https://www.keypedia.com/companies/quva-pharma-inc/d524a08a-f9a6-49fd-8b83-e0508a9163f9) - [IntegraDose Compounding Services LLC](https://www.keypedia.com/companies/integradose-compounding-services-llc/8035ad8c-1993-4ab6-bb81-f3094a178eac) - [Apollo Care, LLC](https://www.keypedia.com/companies/apollo-care-llc/469ed487-7a02-4eb8-beb4-474f95d475f9) - [Vita Pharmacy, LLC dba Talon Compounding Pharmacy](https://www.keypedia.com/companies/vita-pharmacy-llc-dba-talon-compounding-pharmacy/28ed33d2-a435-401b-9ca8-c451dca6b016) - [Avella of Deer Valley dba Avella Specialty Pharmacy](https://www.keypedia.com/companies/avella-of-deer-valley-dba-avella-specialty-pharmacy/e689b0f5-b1ed-4f51-be2f-3bfd18ffab7b) - [OSRX Inc.](https://www.keypedia.com/companies/osrx-inc/aead9fd9-6208-40fd-bc2a-d477072c53ae) - [Athenex Pharma Solutions, LLC](https://www.keypedia.com/companies/athenex-pharma-solutions-llc/d8bf380f-b613-4bd7-831f-33a576776e21) - [Imprimis NJOF, LLC](https://www.keypedia.com/companies/imprimis-njof-llc/7720fb39-8798-4cfd-9e08-9e0f77adaa2c) - [Michael W. Harris, D.O.](https://www.keypedia.com/companies/michael-w-harris-do/f04a6e09-4c55-46a9-b9ce-6dda086d0480) - [RC Outsourcing, LLC](https://www.keypedia.com/companies/rc-outsourcing-llc/7ab10074-d0f6-4d94-893d-1c75a54950cf) ## Related Officers - [Investigator](https://www.keypedia.com/people/demario-l-walls/c69c4c87-f001-45ab-8d7b-b45c60226ff1) - [Writer](https://www.keypedia.com/people/michael-j-donovan/3f7b6f98-6da8-4210-bafb-414e0e5440cf) - [Investigator](https://www.keypedia.com/people/patty-p-kaewussdangkul/1f0961fc-216e-4580-830a-56a76c0e7cea)